5 years ago

Perspectum Secures $36 Million to Advance Liver Disease Diagnostics

  • Perspectum, a UK-based medical software company, has raised $36 million in a funding round co-led by Blue Venture Fund and HealthQuest Capital

  • The company provides non-invasive technology for identifying and monitoring multiple diseases, including liver disorders

  • The funding will be used to commercialize its LiverMultiScan® product for clinical use, expand its CRO business, and develop additional products for biliary disease, diabetes, and cancer.

      • ProblemHealthcare

      "Diagnosing and monitoring liver disease using traditional methods is often inaccurate and expensive. "

      Solution

      "LiverMultiScan® is a software solution that uses existing MRI scans to provide accurate and precise data about liver tissue, helping doctors better diagnose and monitor liver disorders like NAFLD and NASH."

      Covered on